In the News

Marcus Neuroscience Institute Offers Syn-One Test™ to Patients

Marcus Neuroscience Institute Offers Syn-One Test™ to Patients

Specialized neurologic and neurosurgical care center Marcus Neuroscience Institute, part of Baptist Health South Florida, is now offering its patients the Syn-One Test. Sameea Husain Wilson, D.O., director of Movement Disorder Neurology for the institute, cites the simplicity of administering the test, its high level of accuracy, and the speed with which patients get results as the major benefits of the test.

READ MORE
CND Life Sciences

CND Life Sciences

CND Life Sciences is the creator of the Syn-One Test™, the world’s first commercially available test to visualize abnormal, phosphorylated alpha-synuclein in cutaneous nerve fibers. The test is an objective, evidence-based diagnostic tool to aid in the diagnosis of Parkinson’s disease, dementia with Lewy bodies, multiple system atrophy, pure autonomic failure, or REM sleep behavior disorder.